Takeda Pharmaceutical
TAK
#491
Rank
S$61.39 B
Marketcap
S$18.45
Share price
0.28%
Change (1 day)
2.44%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total debt

Total debt on the balance sheet as of September 2025 : S$40.72 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total debt is S$40.72 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2025-03-31S$40.45 B-6.17%
2024-03-31S$43.11 B-1.35%
2023-03-31S$43.70 B-9.58%
2022-03-31S$48.33 B-14.14%
2021-03-31S$56.29 B-16.42%
2020-03-31S$67.35 B-4.01%
2019-03-31S$70.16 B477.17%
2018-03-31S$12.15 B-15.4%
2017-03-31S$14.37 B56.05%
2016-03-31S$9.20 B10.34%
2015-03-31S$8.34 B-20.41%
2014-03-31S$10.48 B36.26%
2013-03-31S$7.69 B-6.44%
2012-03-31S$8.22 B2552.18%
2011-03-31S$0.31 B10.77%
2010-03-31S$0.27 B-7.99%
2009-03-31S$0.30 B571.47%
2008-03-31S$45.31 M-69.72%
2007-03-31S$0.14 B-13.92%
2006-03-31S$0.17 B-39%
2005-03-31S$0.28 B20.9%
2004-03-31S$0.23 B25.25%
2003-03-31S$0.18 B-13.07%
2002-03-31S$0.21 B-6.17%
2001-03-31S$0.23 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$59.41 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$33.12 B-18.66%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
S$78.95 B 93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.54 B 2.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
S$0.14 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$0.85 B-97.90%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
S$70.82 B 73.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$30.96 B-23.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$53.68 B 31.82%๐Ÿ‡บ๐Ÿ‡ธ USA